PODD
$259.10
Insulet
($3.57)
(1.36%)
PODD
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus: $0.05
Revenue: $245.50 Mil
Share
Watch
Guidance announcement made Tuesday, February 23, 2021
Latest EPS
Tuesday, February 23, 2021
What do you expect when PODD reports earnings?
Where is PODD's stock price going from here?
Analysts
Pivots
Resistance
$278.78
$274.52
$266.81
Support
$254.85
$250.59
$242.88
Description
INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes.